Xov Xwm Zoo:
Bioantibody tau ua tiav thawj zaug ntawm cov nyiaj txiag tag nrho ze li 100 lab yuan.Cov nyiaj txiag no tau koom ua ke los ntawm Fang Fund, New Industry Investment, Guoqian Venture Investment, bondshine peev thiab Phoeixe Tree Investment.
Cov nyiaj yuav raug siv los txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhim kho cov khoom siv ntse ntse thiab kev sib koom ua ke thiab kev hloov kho tus kheej OEM / ODM platforms rau cov tshuaj tiv thaiv, #IVD cov khoom, thiab lwm yam kev pabcuam.
Bioantibody tsom mus rau R & D, tsim khoom thiab muag cov khoom siv raw rau IVD thiab biopharmaceuticals.Raws li tus thawj high-efficiency tsom hybridoma cell fusion technology thiab txhawb cell ruaj khov yam tseem ceeb thiab high-throughput ntsuam xyuas platform, lub tuam txhab tau tsim ib tug xov tooj ntawm cov khoom uas muaj kev ua tau zoo piv rau los yog tshaj lub ntiaj teb no thawj-chav kawm IVD raw khoom. , thiab ua tiav kev ua lag luam.Nws tau raug lees paub zoo thiab pheej rov yuav los ntawm cov neeg siv khoom ntawm ntau lub tuam txhab IVD uas muaj npe nrov hauv Suav teb.
Bioantibody tau txij li thaum nws pib tseem muaj tseeb rau nws qhov kev xav tau qub, nrhiav kev tsim kho tshiab thiab kev siv thev naus laus zis txhawb kev kho mob.
Post lub sij hawm: Jan-13-2023